Brimonidine Tartrate

Sandoz Inc🇺🇸 United States

FDA Page

Effective Date: Aug 31, 2021
Approval ID: dfd85672-fa4b-40e3-ac9c-81b8d9e4ffde
Products: 1 registered
Version: 6

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION.BRIMONIDINE TARTRATE ophthalmic solution For Topical Ophthalmic UseInitial U.S. Approval: 1996

Quick Stats

Total Products1

Labelers2

Label Sections33

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.